Americans today are experiencing the most devastating drug crisis in our nation’s history. This is because one drug—fentanyl—has transformed the criminal landscape. Fentanyl is exceptionally cheap to make, exceptionally easy to disguise, and exceptionally deadly to those who take it. It is the leading cause of death for Americans between...

Americans today are experiencing the most devastating drug crisis in our nation’s history. This is because one drug—illicit fentanyl—has transformed the criminal landscape. Illicit fentanyl is exceptionally cheap to make, exceptionally easy to disguise, and exceptionally deadly to those who take it. It is the leading cause of death for...

DEA has been hard at work to undertake a transformation of its own to meet this moment. DEA has acted with urgency to set a new vision, target the global criminal networks most responsible for the influx of fentanyl into the United States, raise public awareness about how just one...

The Drug Enforcement Administration is adjusting the 2020 aggregate production quotas for certain controlled substances in schedule II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine and pseudoephedrine. This increase is in response to the current nationwide COVID-19 public health emergency...

Statement of Thomas Prevoznik Deputy Assistant Administrator Diversion Control Division Drug Enforcement Administration U.S. Department of Justice Before the Subcommittee on Health House Committee on Energy and Commerce U.S. House of Representatives at a hearing entitled “Combatting an epidemic: legislation to help patients with substance use disorders” presented March 3...

Matthew J. Strait, Senior Policy Advisor, Diversion Control Division-DEA; Before the House Energy and Commerce Committee-Subcommittee on Health, for a Hearing Entitled: Cannabis Policy-For the New Decade

Hearing Entitled “Tackling the Opioid Crisis: A Whole-of-Government Approach” December 17, 2019

Statement of Matthew Donahue before the House of Representatives, Energy and Commerce Committee, Subcommittee on Oversight and Investigations for a hearing entitled, Oversight of Federal Efforts to Combat the Spread of Illicit Fentanyl.

Greg Cherundolo Chief of Operations Office of Global Enforcement Drug Enforcement Administration U.S. Department of Justice before the United States Senate Judiciary Committee for hearing entitled: The Countdown: Fentanyl Analogues and the Expiring Emergency Scheduling Order.

Greg Cherundolo Chief of Operations Office of Global Enforcement Drug Enforcement Administration U.S. Department of Justice before the United States Senate Homeland Security and Governmental Affairs Committee